Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ 18,106 $ (24,131)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Change in estimated fair value of contingent liabilities 1,684 (372)
Depreciation and amortization of intangible assets 12,565 3,422
Amortization of premium (discount) on investments, net 150 830
Amortization of debt discount and issuance fees 4,916 7,203
Amortization of commercial license and other economic rights 528 2,958
Loss (gain) on debt extinguishment 4,840 (659)
Share-based compensation 8,405 5,653
Deferred income taxes (12,408) (10,419)
Loss (gain) from short-term investments (13,090) 25,456
Other 238 5,668
Changes in operating assets and liabilities:    
Accounts receivable, net 2,411 (8,398)
Inventory (9,670) 1,251
Accounts payable and accrued liabilities 470 2,114
Income tax receivable and payable 1,072 4,081
Deferred revenue (5,695) 2,215
Other (3,768) 50
Net cash provided by operating activities 10,754 16,922
Cash flows from investing activities:    
Purchase of short-term investments (72,148) (167,374)
Proceeds from sale of short-term investments 109,407 179,431
Proceeds from maturity of short-term investments 31,500 297,005
Other (3,644) (526)
Net cash provided by investing activities 65,115 308,536
Cash flows from financing activities:    
Repurchase of 2023 Notes (108,822) (203,210)
Payments under financing lease obligations (3,801) 0
Proceeds from convertible bond hedge settlement 16,855 0
Payments to convertible bond holders for warrant purchases (16,459) 0
Net proceeds from stock option exercises and ESPP 26,493 421
Taxes paid related to net share settlement of equity awards (5,901) (1,429)
Share repurchase 0 (73,287)
Payments to CVR Holders 0 (1,800)
Net cash used in financing activities (91,635) (279,305)
Effect of exchange rate changes on cash 0 (169)
Net increase (decrease) in cash, cash equivalents and restricted cash (15,766) 45,984
Cash, cash equivalents and restricted cash at beginning of period 47,963 72,273
Cash, cash equivalents and restricted cash at end of period 32,197 118,257
Supplemental disclosure of cash flow information:    
Interest paid 241 597
Restricted cash in other current assets 344 730
Supplemental schedule of non-cash activity:    
Accrued fixed asset purchases 87 63
Accrued inventory purchases 775 1,445
Unrealized loss on AFS investments $ (55) $ (3,541)